ASMB — ASSEMBLY BIOSCIENCES INC

Ownership history in Caption Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ASSEMBLY BIOSCIENCES INC (ASMB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q3)
Avg. % of fund
0.05%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 106,591 -243,209 -69.5% 0.02% $3.6M $34.01
2025 Q3 INITIATED 349,800 — — 0.07% $9.0M $25.60
% of Fund (quarterly)    ASMB price (monthly, adj. close)

Other funds also holding ASMB

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 7.92% B Group, Inc. 4.41% Commodore Capital LP 3Y 2.26% SUPERSTRING CAPITAL MANAGEMENT LP 1.19% Patient Square Capital LP 3Y 0.92% STEMPOINT CAPITAL LP 0.91% MONIMUS CAPITAL MANAGEMENT, LP 0.86% Parkman Healthcare Partners LLC 3Y 0.81% Paradigm Biocapital Advisors LP 3Y 0.58% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.36%
← Back to Caption Management, LLC Holdings